Literature DB >> 19324088

Molecular imaging targeting peptide receptors.

Margret Schottelius1, Hans-Jürgen Wester.   

Abstract

Overexpressed neuropeptide receptors allow tumor visualization using e.g. radiolabeled peptidic receptor ligands and positron emission tomography (PET) or single photon emission computed tomography (SPECT). This review summarizes the development of radiolabeled probes for peptide receptor imaging since the emergence of the technology with a particular focus on peptide radiopharmaceuticals developed during the last 5 years, and highlights the different factors which are decisive during the process of tracer development and evaluation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19324088     DOI: 10.1016/j.ymeth.2009.03.012

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  48 in total

Review 1.  Radiolabeled bombesin derivatives for preclinical oncological imaging.

Authors:  Carolina de Aguiar Ferreira; Leonardo Lima Fuscaldi; Danyelle M Townsend; Domenico Rubello; André Luís Branco de Barros
Journal:  Biomed Pharmacother       Date:  2016-12-29       Impact factor: 6.529

Review 2.  Peptides and peptide hormones for molecular imaging and disease diagnosis.

Authors:  Seulki Lee; Jin Xie; Xiaoyuan Chen
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides.

Authors:  Jonathan S Wall; Tina Richey; Alan Stuckey; Robert Donnell; Sallie Macy; Emily B Martin; Angela Williams; Keiichi Higuchi; Stephen J Kennel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

4.  PEGylated peptide to TIP1 is a novel targeting agent that binds specifically to various cancers in vivo.

Authors:  Vaishali Kapoor; Abhay Kumar Singh; Buck E Rogers; Dinesh Thotala; Dennis E Hallahan
Journal:  J Control Release       Date:  2019-02-11       Impact factor: 9.776

5.  High-yielding aqueous 18F-labeling of peptides via Al18F chelation.

Authors:  Christopher A D'Souza; William J McBride; Robert M Sharkey; Louis J Todaro; David M Goldenberg
Journal:  Bioconjug Chem       Date:  2011-08-09       Impact factor: 4.774

6.  In vivo bacteriophage peptide display to tailor pharmacokinetics of biological nanoparticles.

Authors:  Jessica R Newton-Northup; Marie T Dickerson; Senthil R Kumar; George P Smith; Thomas P Quinn; Susan L Deutscher
Journal:  Mol Imaging Biol       Date:  2014-12       Impact factor: 3.488

7.  Synthesis and evaluation of a bimodal CXCR4 antagonistic peptide.

Authors:  Joeri Kuil; Tessa Buckle; Hushan Yuan; Nynke S van den Berg; Shinya Oishi; Nobutaka Fujii; Lee Josephson; Fijs W B van Leeuwen
Journal:  Bioconjug Chem       Date:  2011-04-19       Impact factor: 4.774

8.  Fully automated GMP production of [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 for clinical use.

Authors:  Irina Velikyan; Ulrika Rosenstrom; Olof Eriksson
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-07-15

9.  Characterization of TCP-1 probes for molecular imaging of colon cancer.

Authors:  Zhonglin Liu; Brian D Gray; Christy Barber; Michael Bernas; Minying Cai; Lars R Furenlid; Andrew Rouse; Charmi Patel; Bhaskar Banerjee; Rongguang Liang; Arthur F Gmitro; Marlys H Witte; Koon Y Pak; James M Woolfenden
Journal:  J Control Release       Date:  2016-08-26       Impact factor: 9.776

10.  Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers.

Authors:  Vaishali Kapoor; David Y A Dadey; Kim Nguyen; Scott A Wildman; Kelly Hoye; Arpine Khudanyan; Nilantha Bandara; Buck E Rogers; Dinesh Thotala; Dennis E Hallahan
Journal:  J Nucl Med       Date:  2016-07-21       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.